These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22500756)

  • 81. [Inborn error of cholesterol biosynthesis: Smith-Lemli-Opitz syndrome].
    Koczok K; V Oláh A; P Szabó G; Oláh É; Török O; Balogh I
    Orv Hetil; 2015 Oct; 156(42):1695-702. PubMed ID: 26551309
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effect of Cholesterol on Membrane Dipole Potential: Atomistic and Coarse-Grained Molecular Dynamics Simulations.
    Shen H; Deng M; Wu Z; Zhang J; Zhang Y; Gao C; Cen C
    J Chem Theory Comput; 2018 Jul; 14(7):3780-3795. PubMed ID: 29791146
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparative molecular dynamics study of lipid membranes containing cholesterol and ergosterol.
    Czub J; Baginski M
    Biophys J; 2006 Apr; 90(7):2368-82. PubMed ID: 16399829
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Basis for rapid efflux of biosynthetic desmosterol from cells.
    Phillips JE; Rodrigueza WV; Johnson WJ
    J Lipid Res; 1998 Dec; 39(12):2459-70. PubMed ID: 9831635
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Anesthetics reduce the magnitude of the membrane dipole potential. Measurements in lipid vesicles using voltage-sensitive spin probes.
    Qin Z; Szabo G; Cafiso DS
    Biochemistry; 1995 Apr; 34(16):5536-43. PubMed ID: 7727414
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
    Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
    Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome.
    Chan YM; Merkens LS; Connor WE; Roullet JB; Penfield JA; Jordan JM; Steiner RD; Jones PJ
    Pediatr Res; 2009 Jun; 65(6):681-5. PubMed ID: 19430384
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects of the membrane dipole potential on the interaction of saquinavir with phospholipid membranes and plasma membrane receptors of Caco-2 cells.
    Asawakarn T; Cladera J; O'Shea P
    J Biol Chem; 2001 Oct; 276(42):38457-63. PubMed ID: 11500495
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome.
    Waterham HR; Wanders RJ
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):340-56. PubMed ID: 11111101
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes.
    Honda A; Tint GS; Salen G; Batta AK; Chen TS; Shefer S
    J Lipid Res; 1995 Jul; 36(7):1595-601. PubMed ID: 7595082
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome.
    Jira PE; Wevers RA; de Jong J; Rubio-Gozalbo E; Janssen-Zijlstra FS; van Heyst AF; Sengers RC; Smeitink JA
    J Lipid Res; 2000 Aug; 41(8):1339-46. PubMed ID: 10946022
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Dipole potential of lipid membranes.
    BROCKMAN H
    Chem Phys Lipids; 1994 Sep; 73(1-2):57-79. PubMed ID: 8001185
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Desmosterol replaces cholesterol for ligand binding function of the serotonin(1A) receptor in solubilized hippocampal membranes: support for nonannular binding sites for cholesterol?
    Singh P; Jafurulla M; Paila YD; Chattopadhyay A
    Biochim Biophys Acta; 2011 Oct; 1808(10):2428-34. PubMed ID: 21763272
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome.
    Batta AK; Salen G; Tint GS; Shefer S
    J Lipid Res; 1995 Nov; 36(11):2413-8. PubMed ID: 8656079
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Probes for protein adduction in cholesterol biosynthesis disorders: Alkynyl lanosterol as a viable sterol precursor.
    Tallman KA; Kim HH; Korade Z; Genaro-Mattos TC; Wages PA; Liu W; Porter NA
    Redox Biol; 2017 Aug; 12():182-190. PubMed ID: 28258022
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: summary of an NICHD conference.
    Opitz JM; de la Cruz F
    Am J Med Genet; 1994 May; 50(4):326-38. PubMed ID: 7632194
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A certain proportion of docosahexaenoic acid tends to revert structural and dynamical effects of cholesterol on lipid membranes.
    Pedroni VI; Sierra MB; Alarcón LM; Verde AR; Appignanesi GA; Morini MA
    Biochim Biophys Acta Biomembr; 2021 Jun; 1863(6):183584. PubMed ID: 33571481
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Role of Cholesterol and its Biosynthetic Precursors on Membrane Organization and Dynamics: A Fluorescence Approach.
    Shrivastava S; Paila YD; Chattopadhyay A
    J Membr Biol; 2023 Apr; 256(2):189-197. PubMed ID: 36781437
    [TBL] [Abstract][Full Text] [Related]  

  • 99. C-Glucosylation as a tool for the prevention of PAINS-induced membrane dipole potential alterations.
    de Matos AM; Blázquez-Sánchez MT; Sousa C; Oliveira MC; de Almeida RFM; Rauter AP
    Sci Rep; 2021 Feb; 11(1):4443. PubMed ID: 33627687
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Non-destructive real-time monitoring and investigation of the self-assembly process using fluorescent probes.
    Ji X; Wang N; Wang J; Wang T; Huang X; Hao H
    Chem Sci; 2024 Mar; 15(11):3800-3830. PubMed ID: 38487216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.